Urearetics Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Urearetics General Information
Description
Developer of an innovative therapy designed to evaluate ureteric compounds as a treatment for heart failure with preserved ejection fraction (HFpEF). The company aims to improve treatment options for patients with HFpEF through the development of urearetic therapies, enabling healthcare professionals to utilize a novel urearetic treatment that improves symptoms and outcomes.
Contact Information
Corporate Office
- Atlanta, GA
- United States
Corporate Office
- Atlanta, GA
- United States
Urearetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 15-Jul-2024 | Completed | Startup | |||
| 1. Accelerator/Incubator | 08-Sep-2021 | Completed | Startup |
Urearetics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biolocity | Accelerator/Incubator | Minority |
Urearetics FAQs
-
Where is Urearetics headquartered?
Urearetics is headquartered in Atlanta, GA.
-
What industry is Urearetics in?
Urearetics’s primary industry is Pharmaceuticals.
-
Is Urearetics a private or public company?
Urearetics is a Private company.
-
What is Urearetics’s current revenue?
The current revenue for Urearetics is .
-
Who are Urearetics’s investors?
Biolocity has invested in Urearetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process